Article
Generation of a CRISPR/Cas edited human induced pluripotent stem cell line DHMi005-A-1 carrying a patient-specific disease-causing point mutation in the TBX5 gene.
Stem cell research - 1 Apr 2022
Lahm Harald, Heinrich Paul, Zierler Elisabeth, Dzilic Elda, Neb Irina, Luzius Tatjana, Doppler Stefanie A, Schneider Stephanie, Lange Rüdiger, Krane Markus, Dreßen Martina
Abstract excerpt
A number of mutations in the human TBX5 gene have been described which cause Holt-Oram syndrome, a severe congenital disease associated with abnormalities in heart and upper limb development. We have used a prime-editing approach to introduce a patient-specific disease-causing TBX5 mutation (c.920_C > A) into an induced pluripotent stem cell (iPSC) line from a healthy donor. The resulting iPSC line provides a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
